Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 17 (1), 11-22

Stem Cell Therapies in Clinical Trials: Progress and Challenges


Stem Cell Therapies in Clinical Trials: Progress and Challenges

Alan Trounson et al. Cell Stem Cell.


Clinical investigations using stem cell products in regenerative medicine are addressing a wide spectrum of conditions using a variety of stem cell types. To date, there have been few reports of safety issues arising from autologous or allogeneic transplants. Many cells administered show transient presence for a few days with trophic influences on immune or inflammatory responses. Limbal stem cells have been registered as a product for eye burns in Europe and mesenchymal stem cells have been approved for pediatric graft versus host disease in Canada and New Zealand. Many other applications are progressing in trials, some with early benefits to patients.

Similar articles

  • The Function of Stem Cells and Their Future Roles in Healthcare
    SH Cedar. Br J Nurs 15 (2), 104-7. PMID 16493287. - Review
    Adult stem cells from bone marrow have been used in the treatment of cancer for many years. Recently, however, interest has developed in the isolation and growth of adult …
  • Concise Review: Hurdles in a Successful Example of Limbal Stem Cell-Based Regenerative Medicine
    G Pellegrini et al. Stem Cells 32 (1), 26-34. PMID 24038592. - Review
    Recent breakthroughs in regenerative medicine have generated enthusiasm and many efforts to explore new therapeutic potentials of both somatic and pluripotent stem cells. …
  • Hepatocyte Transplantation: Waiting for Stem Cells
    D Haridass et al. Curr Opin Organ Transplant 13 (6), 627-32. PMID 19060554. - Review
    The current focus of research aims to reduce the shortage of transplantable cells by the application of stem cell sources or by the conditioning of recipient livers. Ther …
  • Biotherapies in Stroke
    O Detante et al. Rev Neurol (Paris) 170 (12), 779-98. PMID 25459115. - Review
    Stroke is the second leading cause of death worldwide and the most common cause of severe disability. Neuroprotection and repair mechanisms supporting endogenous brain pl …
  • Limbal Stem Cell Transplantation
    M Fernandes et al. Indian J Ophthalmol 52 (1), 5-22. PMID 15132374. - Review
    The past two decades have witnessed remarkable progress in limbal stem cell transplantation. In addition to harvesting stem cells from a cadaver or a live related donor, …
See all similar articles

Cited by 273 PubMed Central articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources